3 van Straalen KR, Tzellos T, Guillem P et al. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa; results of a prospective European cohort study. J Am Acad Dermatol 2021; 85:369-78. 4 Zouboulis CC, Bechara FG, Fritz K et al. [S1 guideline for the treatment of hidradenitis suppurativa/acne inversa * (ICD-10 Ziffer: L73.2)]. J Dtsch Dermatol Ges 2012; 10 (Suppl. 5):S1-31 (in German). 5 Gener G, Canoui-Poitrine F, Revuz JE et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology 2009; 219:148-54. 6 van der Zee HH, Boer J, Prens EP, Jemec GBE. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology 2009; 219:143-7. 7 Dessinioti C, Zisimou C, Tzanetakou V et al. Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up. Clin Exp Dermatol 2016; 41:852-7. 8 Join-Lambert O, Ribadeau-Dumas F, Jullien V et al. Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination.